Neurobehavioral differences in superselective Wada testing with amobarbital versus lidocaine

American Journal of Neuroradiology

Volumn 24, Issue 7, 2003, Pages 1456-1460

  Fitzsimmons, Brian Fred M ^a,b,c   Marshall, Randolph S ^a   Pile Spellman, John ^b   Lazar, Ronald M ^a,b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c Division of Critical Care Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; AMOBARBITAL; LIDOCAINE;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN FUNCTION; BRAIN PERFUSION; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTIONAL ANATOMY; HUMAN; LANGUAGE; MEMORY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PATIENT SELECTION; PREDICTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPATIAL DISCRIMINATION; TECHNIQUE; TREATMENT PLANNING; WADA TEST;

ADULT; AMOBARBITAL; ANESTHETICS, LOCAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LIDOCAINE; NEUROPSYCHOLOGICAL TESTS; NEW YORK;

EID: 0041471633     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The Arteriovenous Malformation Study Group. Arteriovenous malformations of the brain in adults. N Engl J Med 1999;340:1812-1818
2. Rauch RA, Vinuela F, Dion J, et al. Preembolization functional evaluation in brain arteriovenous malformations: the superselective Amytal test. AJNR Am J Neuroradiol 1992;13:303-308
3. Sadato A, Taki W, Nakahara I, et al. Improved provocative test for the embolization of arteriovenous malformations: technical note. Neurol Med Chir (Tokyo) 1994;34:187-190
4. U.S. Food and Drug Administration Office of Science Coordination and Communication. "Off-label" use of marketed drugs, biologics and medical devices. Information Sheets: Guidance for Institutional Review Boards and Clinical Investigators; 1998 update
5. Wechsler D. Wechsler Memory Scale: revised manual. San Antonio, TX: Psychological Corporation/Harcourt Brace Jovanovich; 1987
6. Goodglass H, Kaplan E. Boston Diagnostic Aphasia Examination (BDAE). Philadelphia: Lea & Febiger; 1983
7. Marshall RS, Lazar RM, Krakauer JW, Sharma R. Stimulus context in hemineglect. Brain 1998;121:2003-2010
8. Deveikis JP. Sequential injections of amobarbital sodium and lidocaine for provocative neurological testing in the external carotid circulation. AJNR Am J Neuroradiol 1996;17:1143-1147
9. Lazar RM, Marshall RS, Mohr JP, et al. Unanticipated memory loss during superselective Wada testing for right cerebral arteriovenous malformation. Stroke 2001;32:337-338
10. Martin JH, Ghez C. Pharmacological inactivation in the analysis of the central control of movement. J Neurosci Methods 1999;86:145-159
11. Knowles WD. Normal anatomy and neurophysiology of the hippocampal formation. J Clin Neurophysiol 1992;9:252-263
12. Castellano C, Cabib S, Puglisi-Allegra S. Psychopharmacology of memory modulation: evidence for multiple interaction among neurotransmitters and hormones. Behav Brain Res 1996;77:1-21
13. Doppman JL. Girton M, Oldfield EH. Spinal Wada test. Radiology 1986;161:319-321
14. Horton JA. Dawson RC 3rd. Retinal Wada test. AJNR Am J Neuroradiol 1988;9:1167-1168
15. Lazar RM, Marshall RS, Pile-Spellman J, et al. Anterior translocation of language in patients with left cerebral arteriovenous malformation. Neurology 1997;49:802-808